ESMO Media Releases

A critical trial for types of advanced cancer is the first of its kind to show that precision medicine can slow down the time it takes for a tumour to grow back

Breaking news on innovative cancer treatments will be announced at ESMO 2016, the annual oncology congress organised by the European Society for Medical Oncology, taking place from 7 to 11 October 2016 at Bella Centre in Copenhagen, Denmark.

ESMO launches the first eUpdates for its world-renowned ESMO Clinical Practice Guidelines (CPG)

The European Society for Medical Oncology (ESMO), the leading professional organisation for medical oncology, has revealed the four outstanding recipients of its distinguished awards.

A major new study has found substantial differences in the formulary availability, out-of-pocket costs and actual availability of anti-cancer medicines across Europe.

We are pleased to announce that the ESMO 2018 Annual Congress will take place between 19-23 October 2018 at the Messe Muenchen, Germany

The lively discussion which followed the presentation of ‘A pivotal phase 3 Trial of MABp1 in advanced colorectal cancer'

Details of the first study by one of Europe’s largest cancer centres, the Medical University of Vienna (MUV), assessing the clinical impact and feasibility of the ESMO Magnitude of Clinical Benefit Scale (MCBS) in a real-life context are now available on ESMO Open

Guidelines reflect personalised treatment approach

AIOM adopts ESMO Open as its scientific journal

Phase III trial finds excellent safety and tolerability

Phase III trial confirms efficacy and safety of new second-line agent